Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
641.9 USD | -0.36% | -0.31% | +9.78% |
Mar. 22 | Chemed Insider Sold Shares Worth $1,704,321, According to a Recent SEC Filing | MT |
Mar. 22 | Chemed Insider Sold Shares Worth $7,196,910, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | 2.42B | Sales 2025 * | 2.57B | Capitalization | 9.7B |
---|---|---|---|---|---|
Net income 2024 * | 322M | Net income 2025 * | 354M | EV / Sales 2024 * | 4 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.77 x |
P/E ratio 2024 * |
30.4
x | P/E ratio 2025 * |
27.4
x | Employees | 15,087 |
Yield 2024 * |
0.25% | Yield 2025 * |
0.25% | Free-Float | 39.53% |
Latest transcript on Chemed Corporation
1 day | -0.36% | ||
1 week | -0.31% | ||
Current month | +2.52% | ||
1 month | +2.08% | ||
3 months | +9.86% | ||
6 months | +22.98% | ||
Current year | +9.78% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin McNamara
CEO | Chief Executive Officer | 70 | 85-12-31 |
Michael Witzeman
DFI | Director of Finance/CFO | 52 | 04-12-31 |
Lisa Reinhard
ADM | Chief Administrative Officer | - | 94-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas P. Rice
BRD | Director/Board Member | 74 | 09-04-30 |
Thomas Hutton
BRD | Director/Board Member | 73 | 84-12-31 |
Director/Board Member | 80 | 08-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.18% | 8 M€ | +6.91% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 641.9 | -0.36% | 53,467 |
24-03-27 | 644.3 | +0.98% | 62,225 |
24-03-26 | 638 | -1.05% | 69,680 |
24-03-25 | 644.8 | -0.60% | 50,391 |
24-03-22 | 648.7 | +0.75% | 79,834 |
Delayed Quote Nyse, March 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.78% | 9.74B | |
+1.01% | 99.96B | |
+23.22% | 87.73B | |
+10.42% | 29.33B | |
-3.88% | 18.21B | |
-3.46% | 14.51B | |
+19.69% | 12.22B | |
+31.78% | 12B | |
+0.17% | 11.94B | |
-12.00% | 11.63B |